Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C078219 |
1,2,3,4,7,8-hexachlorodibenzodioxin |
1,2,3,4,7,8-hexachlorodibenzodioxin results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 15703265
|
C495818 |
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one |
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Metformin results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 21186350
|
C438505 |
6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one |
6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
C438505 |
6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one |
6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16873680
|
C473217 |
8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate |
8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 19167487
|
C031143 |
AICA ribonucleotide |
AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 16837613
|
C031143 |
AICA ribonucleotide |
PRKAA1 gene mutant form inhibits the reaction [FSHB protein affects the reaction [AICA ribonucleotide results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 16837613
|
C031143 |
AICA ribonucleotide |
PRKAA1 protein affects the reaction [AICA ribonucleotide affects the reaction [FSHB protein results in increased secretion of Progesterone]] | affects reaction|increases secretion | 16837613
|
C031143 |
AICA ribonucleotide |
PRKAA1 protein affects the reaction [FSHB protein affects the reaction [AICA ribonucleotide results in increased expression of STAR protein]] | affects reaction|increases expression | 16837613
|
C031143 |
AICA ribonucleotide |
AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16873680
|
C031143 |
AICA ribonucleotide |
AICA ribonucleotide results in increased activity of PRKAA1 protein | increases activity | 12519745
|
C031143 |
AICA ribonucleotide |
AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 16020477
|
C031143 |
AICA ribonucleotide |
[AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein] which results in decreased secretion of Progesterone | decreases secretion|increases phosphorylation | 16020477
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in decreased phosphorylation of PRKAA1 protein | decreases phosphorylation | 16990341
|
D013196 |
Dihydrotestosterone |
Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA1 protein] | decreases phosphorylation|decreases reaction | 16990341
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PRKAA1 mRNA | affects expression | 16483693
|
D047310 |
Apigenin |
Apigenin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of PRKAA1 mRNA | affects expression | 17331233
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRKAA1 mRNA | decreases expression | 19150397
|
C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in increased expression of PRKAA1 mRNA | increases expression | 17553608
|
C542815 |
BLX 1002 |
BLX 1002 results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 19052259
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PRKAA1 mRNA | affects expression | 12734012
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of PRKAA1 mRNA | increases expression | 17452286
|
C018021 |
cobaltous chloride |
cobaltous chloride results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16678800
|
C018021 |
cobaltous chloride |
PRKAA1 protein affects the reaction [cobaltous chloride results in increased expression of VEGFA mRNA] | affects reaction|increases expression | 16678800
|
C018021 |
cobaltous chloride |
PRKAA1 protein affects the reaction [cobaltous chloride results in increased secretion of VEGFA protein] | affects reaction|increases secretion | 16678800
|
D003474 |
Curcumin |
Curcumin results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 18790744
|
D003976 |
Diazinon |
Diazinon results in increased expression of PRKAA1 mRNA | increases expression | 17452286
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA1 protein] | decreases phosphorylation|decreases reaction | 16990341
|
D004958 |
Estradiol |
Estradiol results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 15967841
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of PRKAA1 mRNA | decreases expression | 18035473
|
D005576 |
Forskolin |
Forskolin results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 18390901
|
D005576 |
Forskolin |
PNPLA2 protein affects the reaction [Forskolin results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | affects reaction|increases activity|increases phosphorylation | 18390901
|
D005947 |
Glucose |
6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
D005947 |
Glucose |
Apigenin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
D005947 |
Glucose |
Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein | decreases activity|decreases phosphorylation | 16873680
|
D005947 |
Glucose |
Metformin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
D005947 |
Glucose |
resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
D005947 |
Glucose |
Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein | decreases activity|decreases phosphorylation | 19052259
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of and results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases expression|increases phosphorylation | 15297373
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of PRKAA1 mRNA | decreases expression | 18927307
|
D015056 |
1-Methyl-3-isobutylxanthine |
1-Methyl-3-isobutylxanthine results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 18390901
|
D015056 |
1-Methyl-3-isobutylxanthine |
orlistat inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 18390901
|
D007545 |
Isoproterenol |
Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 18390901
|
D007545 |
Isoproterenol |
orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 18390901
|
D007545 |
Isoproterenol |
triacsin C inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 18390901
|
D007545 |
Isoproterenol |
INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | decreases reaction|increases phosphorylation | 19167487
|
D007545 |
Isoproterenol |
Isoproterenol results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 19167487
|
D007545 |
Isoproterenol |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | decreases reaction|increases phosphorylation | 19167487
|
D007545 |
Isoproterenol |
OPC 3911 inhibits the reaction [INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]] | decreases reaction|increases phosphorylation | 19167487
|
D007545 |
Isoproterenol |
orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | decreases reaction|increases phosphorylation | 19167487
|
D007545 |
Isoproterenol |
[PDE3B protein co-treated with AKT1 protein] inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19167487
|
D008687 |
Metformin |
Metformin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
D008687 |
Metformin |
Metformin results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16873680
|
D008687 |
Metformin |
Metformin results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 19052259
|
D008687 |
Metformin |
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Metformin results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 21186350
|
D008687 |
Metformin |
Metformin results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 21186350
|
D008687 |
Metformin |
Metformin results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin inhibits the reaction [FSH protein results in increased expression of HSD3B protein]] | decreases reaction|increases expression | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin inhibits the reaction [FSH protein results in increased expression of STAR protein]] | decreases reaction|increases expression | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin promotes the reaction [FSH protein results in increased phosphorylation of PRKAA1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin results in decreased expression of HSD3B protein] | decreases expression|decreases reaction | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin results in decreased secretion of Progesterone] | decreases reaction|decreases secretion | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 16760380
|
D008687 |
Metformin |
PRKAA1 gene mutant form inhibits the reaction [Metformin results in increased phosphorylation of PRKAA1 protein] | decreases reaction|increases phosphorylation | 16760380
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | decreases reaction|increases phosphorylation | 19167487
|
C060853 |
OPC 3911 |
OPC 3911 inhibits the reaction [INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]] | decreases reaction|increases phosphorylation | 19167487
|
C055122 |
orlistat |
orlistat inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 18390901
|
C055122 |
orlistat |
orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 18390901
|
C055122 |
orlistat |
orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | decreases reaction|increases phosphorylation | 19167487
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PRKAA1 mRNA | increases expression | 19236843
|
D011374 |
Progesterone |
PRKAA1 protein affects the reaction [AICA ribonucleotide affects the reaction [FSHB protein results in increased secretion of Progesterone]] | affects reaction|increases secretion | 16837613
|
D011374 |
Progesterone |
[AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein] which results in decreased secretion of Progesterone | decreases secretion|increases phosphorylation | 16020477
|
D011374 |
Progesterone |
PRKAA1 gene mutant form inhibits the reaction [Metformin results in decreased secretion of Progesterone] | decreases reaction|decreases secretion | 16760380
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16873680
|
C059514 |
resveratrol |
resveratrol results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16873680
|
C059514 |
resveratrol |
resveratrol results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 17464184
|
C059514 |
resveratrol |
resveratrol results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 17438283
|
C059514 |
resveratrol |
STK11 protein promotes the reaction [resveratrol results in increased phosphorylation of PRKAA1 protein] | increases phosphorylation|increases reaction | 17438283
|
D012402 |
Rotenone |
Rotenone results in increased expression of PRKAA1 mRNA | increases expression | 17651460
|
C017947 |
sodium arsenite |
PRKAA1 protein affects the reaction [sodium arsenite results in increased expression of HIF1A protein] | affects reaction|increases expression | 16678800
|
C017947 |
sodium arsenite |
PRKAA1 protein affects the reaction [sodium arsenite results in increased expression of VEGFA mRNA] | affects reaction|increases expression | 16678800
|
C017947 |
sodium arsenite |
PRKAA1 protein affects the reaction [sodium arsenite results in increased secretion of VEGFA protein] | affects reaction|increases secretion | 16678800
|
C017947 |
sodium arsenite |
sodium arsenite results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16678800
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased phosphorylation of PRKAA1 protein | increases phosphorylation | 15703265
|
C034613 |
triacsin C |
triacsin C inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein] | decreases reaction|increases activity|increases phosphorylation | 18390901
|
D014415 |
Tunicamycin |
Tunicamycin results in decreased expression of PRKAA1 mRNA | decreases expression | 17127020
|
D014638 |
Vanadates |
PRKAA1 protein affects the reaction [Vanadates results in increased expression of HIF1A protein] | affects reaction|increases expression | 16678800
|
D014638 |
Vanadates |
PRKAA1 protein affects the reaction [Vanadates results in increased expression of VEGFA mRNA] | affects reaction|increases expression | 16678800
|
D014638 |
Vanadates |
PRKAA1 protein affects the reaction [Vanadates results in increased secretion of VEGFA protein] | affects reaction|increases secretion | 16678800
|
D014638 |
Vanadates |
Vanadates results in increased phosphorylation of and results in increased activity of PRKAA1 protein | increases activity|increases phosphorylation | 16678800 15297373
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.46 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.17 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.50 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.76 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.00 | 11473722 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.09 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.59 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.59 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.30 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.50 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
7.87 | 11874814 16611668 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
7.87 | 16487989 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.68 | 17887948 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
4.11 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.11 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.61 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.26 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
2.64 | 16807698 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
6.12 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.12 | 17967414 16873680 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.11 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.60 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.60 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.39 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.51 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Isoproterenol |
4.79 | 6740701 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.94 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.87 | 15845082 15380490 15665606 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
9.01 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
9.01 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.60 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Apigenin |
2.75 | 17132221 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
2.75 | 16243823 18593918 18462866 19250217 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.75 | 12948864 17289903 19861407 17018787 18497071 14630087 16675129 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.75 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.75 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.75 | 20435547 |
MESH:D019121 |
Burkholderia Infections |
|
orlistat |
6.24 | 17874328 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.07 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.40 | 10355542 16050911 16227642 16097048 15700767 18705752 15673190 16192424 15721981 16011737 3786805 16124888 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.26 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.26 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.00 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.00 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.00 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.00 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.20 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.83 | 18414057 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
6.91 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
6.91 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
6.91 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Isoproterenol |
6.37 | 7544033 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.37 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.68 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.68 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.62 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
9.62 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.62 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.83 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.54 | 19176532 |
MESH:D002916 |
Chylothorax |
|
orlistat |
6.24 | 17003701 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.93 | 15340226 8697196 16354765 12621046 15668235 |
MESH:D003092 |
Colitis |
|
Curcumin |
8.52 | 16782535 16804969 18200517 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.52 | 16474422 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.20 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
5.47 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.47 | 17725105 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.47 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.71 | 17454858 16391804 16303861 17159606 18509181 15273666 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.71 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.51 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.50 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 20055451 10048152 15322242 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
3.67 | 15059100 16823706 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D048909 |
Diabetes Complications |
|
orlistat |
5.44 | 19207292 |
MESH:D003920 |
Diabetes Mellitus |
|
Metformin |
4.99 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.45 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
BLX 1002 |
9.54 | 19052259 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
9.54 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Metformin |
9.54 | 21186350 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
9.54 | 17107852 |
MESH:D003925 |
Diabetic Angiopathies |
|
Metformin |
5.65 | 16385087 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
13.19 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.19 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
13.19 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.11 | 17187935 |
MESH:D003967 |
Diarrhea |
|
orlistat |
4.35 | 20002075 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.31 | 16227642 15027814 7120509 7179309 7440962 10092053 4309450 2869522 17522070 6884620 15968718 6623471 16177239 11566570 9327722 15998439 10915739 21278145 3786805 19336974 19085960 3732212 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.31 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.47 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.68 | 17351913 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.40 | 16487989 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.42 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
9.42 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.42 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.50 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.10 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.10 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.72 | 18566989 19148513 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.80 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.80 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.46 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
1.97 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.72 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
11.14 | 12795759 16239168 15959796 61145 17595544 19224547 12631006 16045604 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
11.14 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.14 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.07 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.60 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
12.60 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.60 | 20067830 |
MESH:D005414 |
Flatulence |
|
orlistat |
6.24 | 20002075 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.31 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.28 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
3.22 | 17596214 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.19 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
3.39 | 18829502 18462866 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.12 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Isoproterenol |
6.56 | 18097624 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.56 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.98 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.37 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
8.37 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.99 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.99 | 16120746 12621046 15340226 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.65 | 17701891 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.63 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.79 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.83 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.35 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 8697196 18606429 16354765 16959395 |
MESH:D017588 |
Hyperandrogenism |
|
Metformin |
5.59 | 15356085 17062894 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.14 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
8.22 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.22 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
BLX 1002 |
8.94 | 19052259 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
8.94 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
orlistat |
8.63 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
8.63 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.75 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.70 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Isoproterenol |
4.84 | 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.96 | 17488730 |
MESH:D007022 |
Hypotension |
|
Isoproterenol |
4.44 | 6740701 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.04 | 18306037 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.20 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.20 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
6.25 | 16466525 12948887 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.25 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Curcumin |
13.61 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
13.61 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
13.61 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
13.61 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
13.61 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.04 | 18200517 18596194 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.14 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
15.65 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Metformin |
15.65 | 17062894 |
MESH:D007333 |
Insulin Resistance |
|
orlistat |
15.65 | 17201808 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
15.65 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.88 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.04 | 18306037 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.34 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.34 | 20008137 |
MESH:C531755 |
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
|
orlistat |
6.24 | 17185156 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
3.92 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.67 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.21 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
3.04 | 18462866 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.85 | 16106398 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.32 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.39 | 16106398 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.43 | 16239168 16943688 17157831 11408273 21278145 16221502 17334410 17174718 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
orlistat |
6.43 | 17404856 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.11 | 14724832 12632512 18481824 12546737 14512876 15996030 17708605 17721639 18277467 16097048 15370692 15818738 18166357 18279442 18054572 15959796 18705752 16011737 15931870 17714472 17922224 18418968 18210741 18156304 18006644 18420326 17565644 15052691 17823541 17631135 16248980 18429990 15893842 18251166 17698563 15876570 12445418 18263696 12389079 18205269 16638106 17976157 16015684 12898905 14716496 12741479 15650968 16033810 15338365 18339082 18412020 17557913 16116963 18187930 17805973 12445421 14620537 12667390 12666154 18395095 16136751 13678700 14748882 14716833 11481614 16027843 15057751 15362042 15673190 10355542 17481882 16192424 17869086 17900296 18472332 17640975 12632514 12609069 15730626 12958196 20821823 18376398 15925388 17766677 17761835 12586293 17944888 17525996 18317297 15123356 12649538 18395914 18472094 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
6.11 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.11 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.11 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.11 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.06 | 16246199 16964402 17285989 15720792 15830285 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
6.06 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
6.06 | 16956363 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.78 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.35 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
12.51 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
12.51 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
12.51 | 19812893 20405173 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.51 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
4.94 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
4.94 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.91 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.64 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
3.17 | 16243823 19359593 18462866 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.17 | 16712894 19931552 17306315 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.17 | 19555203 11884234 |
MESH:D008207 |
Lymphatic Metastasis |
|
orlistat |
5.51 | 18770866 20805790 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
3.31 | 18462866 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.94 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.55 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.31 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.85 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.55 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
8.55 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
8.55 | 8985016 11606380 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.08 | 19453300 |
MESH:D008545 |
Melanoma |
|
Curcumin |
8.96 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Glucose |
8.96 | 14993021 |
MESH:D008545 |
Melanoma |
|
orlistat |
8.96 | 18770866 20805790 |
MESH:D008545 |
Melanoma |
|
resveratrol |
8.96 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.96 | 19082730 16487513 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.78 | 17263510 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.02 | 16166281 16966607 18303189 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.02 | 17112576 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.61 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
6.64 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
6.64 | 17935668 14749477 16490592 17164350 17049120 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
11.10 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
11.10 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
orlistat |
9.46 | 18430571 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
9.46 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
orlistat |
5.09 | 21442799 |
MESH:D009203 |
Myocardial Infarction |
|
Isoproterenol |
8.61 | 17052832 16538859 19595682 19172585 16584858 15740881 16697266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.61 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
8.61 | 16525036 17015251 17188708 16317513 17125593 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.98 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.98 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.25 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.25 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.36 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
4.00 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.01 | 18259882 |
MESH:D009369 |
Neoplasms |
|
orlistat |
7.25 | 18710210 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.25 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.25 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
orlistat |
13.26 | 19381703 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
13.26 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
13.26 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.13 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.18 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
orlistat |
9.18 | 17012255 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.58 | 17356569 15790535 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.22 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.22 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.23 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.89 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.27 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.49 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.34 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.04 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.90 | 15081274 |
MESH:C541083 |
Non-alcoholic Fatty Liver Disease |
|
orlistat |
5.21 | 17404856 |
MESH:D009765 |
Obesity |
|
Curcumin |
6.98 | 19297423 |
MESH:D009765 |
Obesity |
|
orlistat |
6.98 | 20518802 21438711 19046740 18773755 16938137 19461584 20599501 21442799 20002075 20540997 19207292 20065556 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.98 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.23 | 18719352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.89 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
10.18 | 18462866 19020741 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.18 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.18 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.18 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
2.79 | 19401701 19196508 17440100 |
MESH:D010195 |
Pancreatitis |
|
orlistat |
4.49 | 16938137 20065556 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.71 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.83 | 16412576 19232380 16140633 15451049 18619942 11445065 18191903 19114014 11535288 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.74 | 15795934 18197244 15574749 15927086 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.85 | 12520081 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.51 | 10923243 |
MESH:D011041 |
Poisoning |
|
Diazinon |
3.99 | 17603234 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Metformin |
9.84 | 17062894 15356085 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
orlistat |
9.84 | 17201808 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.18 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.28 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.28 | 11118676 11896295 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.53 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Apigenin |
1.93 | 17132221 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
1.93 | 11398177 12497104 15129424 18769126 10851300 18156803 18226269 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.93 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.93 | 15767336 17675339 17718901 17804756 16731767 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.93 | 16039940 |
MESH:D011654 |
Pulmonary Edema |
|
Isoproterenol |
4.85 | 10903255 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.19 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.87 | 17365031 15814490 17975199 17322281 |
MESH:D012035 |
Refsum Disease |
|
orlistat |
5.68 | 20871815 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.18 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.90 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.90 | 17058453 16314181 15827377 16317513 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.67 | 10666014 18379247 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.25 | 16611668 11874814 17119214 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.46 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.49 | 16611668 17119214 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.71 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.78 | 18462866 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.75 | 18389075 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.69 | 6418539 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
15.88 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
15.88 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
15.88 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.88 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.88 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.89 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.49 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.08 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
orlistat |
3.08 | 19381703 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
3.16 | 19188055 16631530 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.14 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.50 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.28 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.87 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
4.77 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.77 | 16712894 11723127 17306315 16452187 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.87 | 18462866 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.87 | 16487989 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.43 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.43 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.76 | 17044934 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.03 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.19 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Isoproterenol |
9.39 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.39 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
Isoproterenol |
5.29 | 18097624 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.85 | 15886252 |